December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Eric Bouffet: New hope for children and adults with hemianopia
Dec 1, 2024, 09:54

Eric Bouffet: New hope for children and adults with hemianopia

Eric Bouffet, Professor of Paediatrics at the University of Toronto, posted on LinkedIn about recent paper by him as co-author, titled “A telerehabilitation program to improve visual perception in children and adolescents with hemianopia consecutive to a brain tumor: a single-arm feasibility and proof-of-concept trial”, published on Science Direct.

Authors: Mariana Misawa, Inci Yaman Bajin, Bill Zhang, Monica Daibert-Nido, Danielle Tchao, Eduardo Garcia-Giler, Kyle Cheung, Lora Appel, Pi Nasir, Arun Reginald, Uri Tabori, Ute Bartels, Vijay Ramaswamy, Samuel N. Markowitz, Eric Bouffet, Michael Reber

Eric Bouffet: New hope for children and adults with hemianopia

“New hope for children and probably adults with hemianopia

This work initiated by Dr. Michael Reber shows that a virtual rehabilitation program using goggles can significantly improve the visual field of children with hemianopia after 8 weeks. This has been an incredible experience and rich collaboration between UHN and Sickkids with funding from the Meagan Bebenek Foundation.
And more to come with 2 larger studies in Canada and in Europe!
Congrats Michael!”

Dr. Eric Bouffet holds the position of Professor of Paediatrics at the University of Toronto and serves as the Garron Family Chair in Childhood Cancer Research, as well as Head of the Neuro-Oncology Section within the Division of Haematology/Oncology at The Hospital for Sick Children (SickKids) in Toronto, Canada. He previously served as President of the International Society of Paediatric Oncology (SIOP) from 2016 to 2019 and currently holds the position of Advocacy Chair for SIOP. Since 2003, he has chaired the Canadian Paediatric Brain Tumour Consortium. Dr. Bouffet is also a steering committee member of the Brain Tumour Committee of the Children’s Oncology Group (COG). His research primarily focuses on pediatric brain tumors, with a particular interest in clinical trials.